ONC
Price
$269.63
Change
-$6.90 (-2.50%)
Updated
Jun 13, 04:59 PM (EDT)
Capitalization
32.02B
70 days until earnings call
ZLAB
Price
$40.99
Change
-$2.04 (-4.74%)
Updated
Jun 13, 04:59 PM (EDT)
Capitalization
4.83B
59 days until earnings call
Interact to see
Advertisement

ONC vs ZLAB

Header iconONC vs ZLAB Comparison
Open Charts ONC vs ZLABBanner chart's image
BeOne Medicines
Price$269.63
Change-$6.90 (-2.50%)
Volume$4.89K
Capitalization32.02B
Zai Lab
Price$40.99
Change-$2.04 (-4.74%)
Volume$16.68K
Capitalization4.83B
ONC vs ZLAB Comparison Chart
Loading...
ONC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZLAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ONC vs. ZLAB commentary
Jun 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ONC is a Buy and ZLAB is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 13, 2025
Stock price -- (ONC: $276.53 vs. ZLAB: $43.03)
Brand notoriety: ONC and ZLAB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ONC: 175% vs. ZLAB: 143%
Market capitalization -- ONC: $32.02B vs. ZLAB: $4.83B
ONC [@Biotechnology] is valued at $32.02B. ZLAB’s [@Biotechnology] market capitalization is $4.83B. The market cap for tickers in the [@Biotechnology] industry ranges from $352B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ONC’s FA Score shows that 0 FA rating(s) are green whileZLAB’s FA Score has 0 green FA rating(s).

  • ONC’s FA Score: 0 green, 5 red.
  • ZLAB’s FA Score: 0 green, 5 red.
According to our system of comparison, both ONC and ZLAB are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ONC’s TA Score shows that 6 TA indicator(s) are bullish while ZLAB’s TA Score has 6 bullish TA indicator(s).

  • ONC’s TA Score: 6 bullish, 4 bearish.
  • ZLAB’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both ONC and ZLAB are a good buy in the short-term.

Price Growth

ONC (@Biotechnology) experienced а +7.60% price change this week, while ZLAB (@Biotechnology) price change was +17.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.03%. For the same industry, the average monthly price growth was +20.17%, and the average quarterly price growth was +6.87%.

Reported Earning Dates

ONC is expected to report earnings on Aug 22, 2025.

ZLAB is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+8.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ONC($32B) has a higher market cap than ZLAB($4.83B). ZLAB YTD gains are higher at: 64.299 vs. ONC (49.710). ONC has higher annual earnings (EBITDA): -116.48M vs. ZLAB (-236.44M). ONC has more cash in the bank: 2.52B vs. ZLAB (757M). ZLAB has less debt than ONC: ZLAB (192M) vs ONC (997M). ONC has higher revenues than ZLAB: ONC (4.18B) vs ZLAB (418M).
ONCZLABONC / ZLAB
Capitalization32B4.83B663%
EBITDA-116.48M-236.44M49%
Gain YTD49.71064.29977%
P/E RatioN/AN/A-
Revenue4.18B418M999%
Total Cash2.52B757M332%
Total Debt997M192M519%
FUNDAMENTALS RATINGS
ONC vs ZLAB: Fundamental Ratings
ONC
ZLAB
OUTLOOK RATING
1..100
1517
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
53
Fair valued
PROFIT vs RISK RATING
1..100
68100
SMR RATING
1..100
9194
PRICE GROWTH RATING
1..100
4036
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ZLAB's Valuation (53) in the Biotechnology industry is in the same range as ONC (61). This means that ZLAB’s stock grew similarly to ONC’s over the last 12 months.

ONC's Profit vs Risk Rating (68) in the Biotechnology industry is in the same range as ZLAB (100). This means that ONC’s stock grew similarly to ZLAB’s over the last 12 months.

ONC's SMR Rating (91) in the Biotechnology industry is in the same range as ZLAB (94). This means that ONC’s stock grew similarly to ZLAB’s over the last 12 months.

ZLAB's Price Growth Rating (36) in the Biotechnology industry is in the same range as ONC (40). This means that ZLAB’s stock grew similarly to ONC’s over the last 12 months.

ZLAB's P/E Growth Rating (100) in the Biotechnology industry is in the same range as ONC (100). This means that ZLAB’s stock grew similarly to ONC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ONCZLAB
RSI
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 10 days ago
76%
Bullish Trend 2 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 17 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
ONC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZLAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RPRX35.271.22
+3.58%
Royalty Pharma plc
MGEE89.00-0.15
-0.17%
MGE Energy
EXFY2.35-0.08
-3.29%
Expensify
PPBT2.46-0.10
-3.91%
Purple Biotech Ltd
OST6.61-0.29
-4.20%
Ostin Technology Group Co Ltd

ONC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ONC has been loosely correlated with ZLAB. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ONC jumps, then ZLAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ONC
1D Price
Change %
ONC100%
+5.38%
ZLAB - ONC
54%
Loosely correlated
+3.94%
MDGL - ONC
42%
Loosely correlated
+0.98%
WXXWY - ONC
37%
Loosely correlated
+4.88%
AXON - ONC
37%
Loosely correlated
-0.41%
GOSS - ONC
35%
Loosely correlated
-1.55%
More

ZLAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZLAB has been loosely correlated with ONC. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ZLAB jumps, then ONC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZLAB
1D Price
Change %
ZLAB100%
+3.94%
ONC - ZLAB
52%
Loosely correlated
+5.38%
MGTX - ZLAB
37%
Loosely correlated
+1.70%
VERV - ZLAB
37%
Loosely correlated
-1.10%
ABCL - ZLAB
36%
Loosely correlated
-2.48%
ATXS - ZLAB
36%
Loosely correlated
-3.28%
More